BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34372826)

  • 1. Characteristics of patients meeting the new definition of pre-capillary pulmonary hypertension (Nice 2018) in a single Japanese pulmonary hypertension center.
    Yamamoto K; Tanabe N; Takahashi Y; Naito A; Sekine A; Suda R; Jujo Sanada T; Sugiura T; Shigeta A; Sakao S; Tatsumi K
    BMC Pulm Med; 2021 Aug; 21(1):260. PubMed ID: 34372826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined pre- and post-capillary pulmonary hypertension: The clinical implications for patients with heart failure.
    Ibe T; Wada H; Sakakura K; Ugata Y; Maki H; Yamamoto K; Seguchi M; Taniguchi Y; Jinnouchi H; Momomura SI; Fujita H
    PLoS One; 2021; 16(3):e0247987. PubMed ID: 33651852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the new World Symposium on Pulmonary Hypertension definition of pulmonary hypertension on the prevalence of pre-capillary pulmonary hypertension.
    Sinan ÜY; Çetinarslan Ö; Arat Özkan A; Ersanlı MK; Küçükoğlu MS
    Turk Kardiyol Dern Ars; 2019 Oct; 47(7):594-598. PubMed ID: 31582683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild pulmonary hemodynamic alterations in patients with systemic sclerosis: relevance of the new 2022 ESC/ERS definition of pulmonary hypertension and impact on mortality.
    Puigrenier S; Giovannelli J; Lamblin N; De Groote P; Fertin M; Bervar JF; Lamer A; Edmé JL; Balquet MH; Sobanski V; Launay D; Hachulla É; Sanges S
    Respir Res; 2022 Oct; 23(1):284. PubMed ID: 36243869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the new pulmonary hypertension definition on long-term mortality in patients with severe aortic stenosis undergoing valve replacement.
    Maeder MT; Weber L; Weilenmann D; Chronis J; Joerg L; Pohle S; Haager PK; Brutsche M; Neumann T; Schoch OD; Rickli H
    Clin Cardiol; 2021 Sep; 44(9):1276-1285. PubMed ID: 34219245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left heart abnormalities in connective tissue disease patients with pre-capillary pulmonary hypertension as well as borderline mean pulmonary arterial pressure.
    Tsuchida K; Yamada H; Yamasaki Y; Suzuki K; Kongoji K; Akashi Y; Ozaki S
    Mod Rheumatol; 2015 Sep; 25(5):744-7. PubMed ID: 25736353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study.
    Karia N; Howard L; Johnson M; Kiely DG; Lordan J; McCabe C; Pepke-Zaba J; Ong R; Preiss M; Knight D; Muthurangu V; Coghlan JG
    Eur Heart J; 2023 Nov; 44(44):4678-4691. PubMed ID: 37619574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
    Caravita S; Faini A; Carolino D'Araujo S; Dewachter C; Chomette L; Bondue A; Naeije R; Parati G; Vachiéry JL
    PLoS One; 2018; 13(6):e0199164. PubMed ID: 29920539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of Pulmonary Vascular Resistance and Diastolic Pressure Gradient on the New Definition of Combined Post-Capillary Pulmonary Hypertension.
    Sugimoto K; Yoshihisa A; Nakazato K; Yokokawa T; Misaka T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Ishida T; Takeishi Y
    Int Heart J; 2020; 61(2):301-307. PubMed ID: 32224602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the new definition of pulmonary hypertension according to world symposium of pulmonary hypertension 2018 on diagnosis of post-capillary pulmonary hypertension.
    Pfeuffer-Jovic E; Weiner S; Wilkens H; Schmitt D; Frantz S; Held M
    Int J Cardiol; 2021 Jul; 335():105-110. PubMed ID: 33823213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic Definition of Pulmonary Hypertension: Commentary on the Proposed Change by the 6th World Symposium on Pulmonary Hypertension].
    Rosenkranz S; Diller GP; Dumitrescu D; Ewert R; Ghofrani HA; Grünig E; Halank M; Held M; Kaemmerer H; Klose H; Kovacs G; Konstantinides S; Lang IM; Lange TJ; Leuchte H; Mayer E; Olschewski A; Olschewski H; Olsson KM; Opitz C; Schermuly RT; Seeger W; Wilkens H; Hoeper MM
    Dtsch Med Wochenschr; 2019 Sep; 144(19):1367-1372. PubMed ID: 31277079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study.
    Maron BA; Brittain EL; Hess E; Waldo SW; Barón AE; Huang S; Goldstein RH; Assad T; Wertheim BM; Alba GA; Leopold JA; Olschewski H; Galiè N; Simonneau G; Kovacs G; Tedford RJ; Humbert M; Choudhary G
    Lancet Respir Med; 2020 Sep; 8(9):873-884. PubMed ID: 32730752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension.
    Tedford RJ; Beaty CA; Mathai SC; Kolb TM; Damico R; Hassoun PM; Leary PJ; Kass DA; Shah AS
    J Heart Lung Transplant; 2014 Mar; 33(3):289-97. PubMed ID: 24462554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes.
    Palazzini M; Dardi F; Manes A; Bacchi Reggiani ML; Gotti E; Rinaldi A; Albini A; Monti E; Galiè N
    Eur J Heart Fail; 2018 Feb; 20(2):248-255. PubMed ID: 28464427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary artery acceleration time in identifying pulmonary hypertension patients with raised pulmonary vascular resistance.
    Tossavainen E; Söderberg S; Grönlund C; Gonzalez M; Henein MY; Lindqvist P
    Eur Heart J Cardiovasc Imaging; 2013 Sep; 14(9):890-7. PubMed ID: 23295626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
    Simonneau G; Montani D; Celermajer DS; Denton CP; Gatzoulis MA; Krowka M; Williams PG; Souza R
    Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30545968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the updated hemodynamic definitions on diagnosis rates of pulmonary hypertension.
    Tanyeri S; Akbal OY; Keskin B; Hakgor A; Karagoz A; Tokgoz HC; Dogan C; Bayram Z; Kulahcioglu S; Erdogan E; Balaban I; Ceneli D; Acar RD; Tanboga IH; Ozdemir N; Kaymaz C
    Pulm Circ; 2020; 10(3):2045894020931299. PubMed ID: 32922744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary arterial hypertension with below threshold pulmonary vascular resistance.
    Ratwatte S; Anderson J; Strange G; Corrigan C; Collins N; Celermajer DS; Dwyer N; Feenstra J; Keating D; Kotlyar E; Lavender M; Whitford H; Whyte K; Williams T; Wrobel JP; Keogh A; Lau EM;
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32341105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic heterogeneity of connective tissue disease patients with borderline mean pulmonary artery pressure and its distinctive characters from those with normal pulmonary artery pressure: a retrospective study.
    Asari Y; Yamasaki Y; Tsuchida K; Suzuki K; Akashi YJ; Okazaki T; Ozaki S; Yamada H; Kawahata K
    Clin Rheumatol; 2018 Dec; 37(12):3373-3380. PubMed ID: 29777409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of pulmonary impedance estimation to predict right ventricular dysfunction in pulmonary hypertension.
    Hungerford SL; Kearney K; Song N; Bart N; Kotlyar E; Lau E; Jabbour A; Hayward CS; Muller DWM; Adji A
    ESC Heart Fail; 2023 Jun; 10(3):1811-1821. PubMed ID: 36896830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.